Amb. A M Shahid (Former Diplomat):Pakistan-China Business-to-Business Investment Conference on Pharmaceuticals, Healthcare and Biotechnology has proved to be a great successful event as it has produced magnificent results in terms of interaction and signature of MoUs and agreements between the firms and companies from Pakistan and China. Chinese investors enjoy government's full support and facilitation for investment in Pakistan's pharmaceutical and healthcare sector. Pakistan's pharmaceutical and healthcare market vast investment potential. Drug Regulatory Authority of Pakistan has been transformed into a vibrant institution over the past year as the registration process for medical devices, which previously took around two and a half years, has been reduced to about twenty days through digitization. DRAP processed four thousand and seven hundred registration cases during the last eight months. Under CPEC 2.0 huge investment from China is expected in Pakistan.